Rhoen Klinikum (ETR:RHK) Given a €25.50 Price Target by Warburg Research Analysts

Rhoen Klinikum (ETR:RHK) received a €25.50 ($29.65) price target from investment analysts at Warburg Research in a research report issued to clients and investors on Thursday, April 11th, Borsen Zeitung reports. The brokerage currently has a “neutral” rating on the stock. Warburg Research’s price objective would suggest a potential downside of 4.67% from the stock’s previous close.

Other analysts also recently issued reports about the stock. Independent Research set a €26.00 ($30.23) target price on shares of Rhoen Klinikum and gave the stock a “neutral” rating in a research report on Monday, April 1st. Credit Suisse Group set a €17.00 ($19.77) target price on shares of Rhoen Klinikum and gave the stock a “sell” rating in a research report on Wednesday, January 23rd. Berenberg Bank set a €23.50 ($27.33) target price on shares of Rhoen Klinikum and gave the stock a “neutral” rating in a research report on Thursday, April 11th. Finally, Kepler Capital Markets set a €19.00 ($22.09) target price on shares of Rhoen Klinikum and gave the stock a “sell” rating in a research report on Monday, April 1st. Four equities research analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. The stock currently has a consensus rating of “Sell” and a consensus price target of €22.10 ($25.70).

Rhoen Klinikum stock traded up €0.15 ($0.17) during trading hours on Thursday, hitting €26.75 ($31.10). The company had a trading volume of 32,269 shares, compared to its average volume of 43,281. The firm has a market cap of $1.79 billion and a PE ratio of 36.64. The company has a debt-to-equity ratio of 9.10, a quick ratio of 1.53 and a current ratio of 1.76. Rhoen Klinikum has a fifty-two week low of €21.06 ($24.49) and a fifty-two week high of €28.30 ($32.91).

Rhoen Klinikum Company Profile

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services primarily in the areas of cardiovascular, neurological disorders, oncology, pneumology, orthopedic, accident, and surgeries; rehabilitation and nursing services to the elderly; and thoracic, tumors, and psychosomatic, as well as spinal, column, and joints diseases.

Recommended Story: What is channel trading?

Analyst Recommendations for Rhoen Klinikum (ETR:RHK)

Receive News & Ratings for Rhoen Klinikum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhoen Klinikum and related companies with MarketBeat.com's FREE daily email newsletter.